Ta Win makes foray into pharma industry, invests RM20.8m in Royce Pharma


From left are Royce Pharma Manufacturing president Zainal Ariff Tan Sri Mahmood and group deputy president Datuk Chandrasekar Suppiah; Deputy Human Resources Minister Awang Hashim Awang Hashim while Ta Win Holdings was presented by its group managing director Datuk Seri Ngu Tieng Ung and executive director Tan Poo Chuan.

KUALA LUMPUR: Ta Win Holdings Bhd’s subsidiary is venturing into the pharmaceutical industry through its RM20.85mil investment in Royce Pharma Manufacturing Sdn Bhd.

It said in a statement on Monday its healthcare arm Ta Win Copper Biohealth Sdn Bhd (TWCB) agreed to acquire a 32.5% stake in Royce Pharma, marking the first investment in the pharmaceutical industry.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Gulf IPO boom fizzles
Miniso helps rewrite toy sector story
Caught in the Fed’s crossfire
Converse bets on China for revival
RHB Bank stamps its mark�
The bond conundrum
Where innovation meets tradition
Aijek’s sustainable second act
AI binge tests risk appetite
The cost of climate resilience

Others Also Read